VTRS stock news
This page provides real-time market news, earnings updates, and company announcements related to Viatris Inc. (VTRS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-13 12:43 EST
Viatris Shares Plummet 5.16% on Strong Earnings Despite Surging 425th-Ranked Volume
101 finance2026-02-27 01:01:16
UBS Raises Viatris (VTRS) Price Target as Cost Savings and Growth Outlook Improve
Finviz2026-02-28 17:42:47
Spotting Top Performers: Viatris (NASDAQ:VTRS) and Generic Drug Stocks in the Fourth Quarter
101 finance2026-03-03 19:57:17
Zoetis Tumbles 2.35% to 370th in Daily Trading Volume Amid Strong Q4 Earnings and Dividend Hike
101 finance2026-03-04 00:19:20
TBPH Stock Plunges 26% on Failure of Late-Stage MSA Study
Finviz2026-03-04 16:37:04
Generic Pharmaceuticals Stocks Q4 Summary: Amphastar Pharmaceuticals (NASDAQ:AMPH)
101 finance2026-03-05 09:45:09
Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates
Finviz2026-03-05 12:03:12
Viatris (VTRS): Should You Buy, Sell, or Hold After Q4 Results?
101 finance2026-03-11 01:21:42
Q4 Financial Results Overview: Amneal (NASDAQ:AMRX) and Other Companies in the Generic Pharmaceuticals Sector
101 finance2026-03-11 14:04:07
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
Finviz2026-03-19 12:34:28
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
Finviz2026-03-19 12:34:28
Damora Tumbles 25% as Technical Signals Flash Red
101 finance2026-03-20 00:48:46
Theravance Reports Fourth Quarter Earnings and Revenue Below Expectations
101 finance2026-03-20 19:51:48
Mineralys Drops 9.48% as Technical Indicators Weaken and Analyst Opinions Remain Divided
101 finance2026-03-24 01:18:46
Ascentage Plunges 19% Amid Weak Fundamentals and Bearish Signals
101 finance2026-03-24 01:57:40
Viatris's Effexor GAD Approval in Japan: A First-in-Class Win or Overpriced Incremental Move?
101 finance2026-03-29 21:52:00
Viatris Tumbles on Failed Trial, But Volume Tells a Cautious Story
101 finance2026-04-02 09:15:41
5 Lesser-Known Pharmaceutical Stocks to Consider as Industry Rebound Accelerates
101 finance2026-04-02 15:03:56
Zacks Industry Outlook Features Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics, and Avalo Therapeutics
101 finance2026-04-06 16:18:43
Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Finviz2026-04-10 11:03:12
Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Finviz2026-04-10 11:03:14
Here's the way AMRX is leveraging the demand for GLP-1 via its manufacturing operations
101 finance2026-04-10 15:57:55
AMRX: 3 Key Factors Fueling Amneal's Projections for 2026
101 finance2026-04-10 16:06:45
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026
Finviz2026-04-13 11:00:09
TBPH Stock Plunges 26% on Failure of Late-Stage MSA Study
Finviz2026-03-04 16:37:04
Generic Pharmaceuticals Stocks Q4 Summary: Amphastar Pharmaceuticals (NASDAQ:AMPH)
101 finance2026-03-05 09:45:09
Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates
Finviz2026-03-05 12:03:12
Viatris (VTRS): Should You Buy, Sell, or Hold After Q4 Results?
101 finance2026-03-11 01:21:42
Q4 Financial Results Overview: Amneal (NASDAQ:AMRX) and Other Companies in the Generic Pharmaceuticals Sector
101 finance2026-03-11 14:04:07
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
Finviz2026-03-19 12:34:28
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
Finviz2026-03-19 12:34:28
Damora Tumbles 25% as Technical Signals Flash Red
101 finance2026-03-20 00:48:46
Theravance Reports Fourth Quarter Earnings and Revenue Below Expectations
101 finance2026-03-20 19:51:48
Mineralys Drops 9.48% as Technical Indicators Weaken and Analyst Opinions Remain Divided
101 finance2026-03-24 01:18:46
Ascentage Plunges 19% Amid Weak Fundamentals and Bearish Signals
101 finance2026-03-24 01:57:40
Viatris's Effexor GAD Approval in Japan: A First-in-Class Win or Overpriced Incremental Move?
101 finance2026-03-29 21:52:00
Viatris Tumbles on Failed Trial, But Volume Tells a Cautious Story
101 finance2026-04-02 09:15:41
5 Lesser-Known Pharmaceutical Stocks to Consider as Industry Rebound Accelerates
101 finance2026-04-02 15:03:56
Zacks Industry Outlook Features Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics, and Avalo Therapeutics
101 finance2026-04-06 16:18:43
Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Finviz2026-04-10 11:03:12
Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Finviz2026-04-10 11:03:14
Here's the way AMRX is leveraging the demand for GLP-1 via its manufacturing operations
101 finance2026-04-10 15:57:55
AMRX: 3 Key Factors Fueling Amneal's Projections for 2026
101 finance2026-04-10 16:06:45
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026
Finviz2026-04-13 11:00:09
VTRS stock chart
VTRS stock detailsVTRS stock price change
On the last trading day, VTRS stock closed at 13.47 USD, with a price change of -1.03% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more